ישראל - עברית - Ministry of Health

inovamed ltd - gabapentin - קפסולות - gabapentin 300 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy (neuralgia).

ישראל - עברית - Ministry of Health

inovamed ltd - gabapentin - קפסולות - gabapentin 400 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.for the treatment of neuropathic pain in diabetic neuropathy or postherpetic neuropathy (neuralgia).

ישראל - עברית - Ministry of Health

j-c health care ltd - haloperidol - תמיסה (פומי) - haloperidol 2 mg/ml - haloperidol - haloperidol - antipsychotic, psychomotor sedative. additionally, in pediatrics, for short-term treatment of tics and vomiting (gilles de la tourettes syndrome).

ישראל - עברית - Ministry of Health

eli lilly israel ltd - olanzapine 210 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

ישראל - עברית - Ministry of Health

eli lilly israel ltd - olanzapine 300 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

ישראל - עברית - Ministry of Health

eli lilly israel ltd - olanzapine as pamoate monohydrate 405 mg - powder for suspension for injection - olanzapine - zypadhera is indicated for the treatment of schizophrenia.the use of zypadhera is limited to patients who have been diagnosed as non-compliant regarding taking prescribed medicines and as a consequence are prone to outbursts of psychotic episodes .zypadhera is not to be used in patients whose condition is adequately controlled with oral zyprexa .zypadhera is available only through a restricted program which will be conducted according to zypadhera eu risk management plan.for a patient to receive treatment, the prescribers , injection administrators, pharmacists and patients must all be trained on the appropriate elements of the zypadhera risk management plan. the zypadhera risk management plan has been developed to enable the safe use of zypadhera in patients, including the management of those patients who develop post-injection delirium and sedation syndrome. in addition to mandating label language around this risk, this plan includes education and training activities to the following target audience as appr

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - hydroxyzine hydrochloride 25 mg - tablets - hydroxyzine - anxiety and tension. pruritus. behavior disturbances in children. preoperative sedation.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - hydroxyzine hydrochloride 25 mg - tablets - hydroxyzine - anxiety and tension. pruritus. behavior disturbances in children. preoperative sedation.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 1 mg/ml - midazolam - midazolam - premedication before induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration). status epilepticus.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - midazolam - תמיסה להזרקה - midazolam 5 mg/ml - midazolam - midazolam - premedication befor induction of anesthesia (i.m). basal sedation before diagnostic or surgical interventions carried out under local anesthesia (i.v. administration). induction and maintenance of anesthesia. as an induction agent in inhalation anesthesia or a sleep-inducing component in combined anesthesia, including total intravenous anesthesia (i.v. injection, i.v. infusion). ataralgesia in combination with ketamine in children (i.m. administration).status epilepticus.